{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:06:24Z","timestamp":1792303584248,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005297","name":"Uniwersytet Medyczny w Bialymstoku","doi-asserted-by":"publisher","award":["N\/ST\/ZB\/15\/001\/1143 and N\/ST\/ZB\/15\/003\/1143"],"award-info":[{"award-number":["N\/ST\/ZB\/15\/001\/1143 and N\/ST\/ZB\/15\/003\/1143"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12944-018-0855-9","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T09:40:39Z","timestamp":1536745239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Natalia","family":"Wasilewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bobrus-Chociej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Harasim-Symbor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugeniusz","family":"Taras\u00f3w","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Wojtkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Chabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz M.","family":"Lebensztejn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,12]]},"reference":[{"issue":"9945","key":"855_CR1","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","volume":"384","author":"M Ng","year":"2014","unstructured":"Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766\u201381.","journal-title":"Lancet"},{"issue":"10113","key":"855_CR2","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","volume":"390","author":"(NCD-RisC) NRFC","year":"2017","unstructured":"(NCD-RisC) NRFC. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults. Lancet. 2017;390(10113):2627\u201342.","journal-title":"Lancet"},{"issue":"4","key":"855_CR3","first-page":"641","volume":"70","author":"Z Ku\u0142aga","year":"2016","unstructured":"Ku\u0142aga Z, Grajda A, Gurzkowska B, Wojty\u0142o MA, G\u00f3\u017ad\u017a M, Litwin MS. The prevalence of overweight and obesity among polish school- aged children and adolescents. Przegl Epidemiol. 2016;70(4):641\u201351.","journal-title":"Przegl Epidemiol"},{"key":"855_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.80","volume":"1","author":"EM Brunt","year":"2015","unstructured":"Brunt EM, Wong VW, Nobili V, Day CP, Sookoian S, Maher JJ, et al. Nonalcoholic fatty liver disease. Nat Rev Dis Primers. 2015;1:15080.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"855_CR5","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jpeds.2012.08.043","volume":"162","author":"JA Welsh","year":"2013","unstructured":"Welsh JA, Karpen S, Vos MB. Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. J Pediatr. 2013;162(3):496\u2013500.e1.","journal-title":"J Pediatr"},{"issue":"1","key":"855_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"1","key":"855_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2478\/jomb-2014-0049","volume":"34","author":"CD Corte","year":"2015","unstructured":"Corte CD, Ferrari F, Villani A, Nobili V. Epidemiology and Natural history of NAFLD. J Med Biochemist. 2015;34(1):13\u20137.","journal-title":"J Med Biochemist"},{"issue":"2","key":"855_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jhep.2017.11.016","volume":"68","author":"J George","year":"2018","unstructured":"George J, Anstee Q, Ratziu V, Sanyal A. NAFLD: the evolving landscape. J Hepatol. 2018;68(2):227\u20139.","journal-title":"J Hepatol"},{"issue":"2","key":"855_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","volume":"68","author":"A Lonardo","year":"2018","unstructured":"Lonardo A, Nascimbeni F, Mantovani A, Targher G. Hypertension, diabetes, atherosclerosis and NASH: cause or consequence? J Hepatol. 2018;68(2):335\u201352.","journal-title":"J Hepatol"},{"key":"855_CR10","doi-asserted-by":"crossref","unstructured":"Petta S, Gastaldelli A, Rebelos E, Bugianesi E, Messa P, Miele L, et al. Pathophysiology of non alcoholic fatty liver disease. Int J Mol Sci. 2016;17:(12):2082\u2013107.","DOI":"10.3390\/ijms17122082"},{"issue":"2","key":"855_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","volume":"68","author":"F Marra","year":"2018","unstructured":"Marra F, Svegliati-Baroni G. Lipotoxicity and the gut-liver axis in NASH pathogenesis. J Hepatol. 2018;68(2):280\u201395.","journal-title":"J Hepatol"},{"issue":"2","key":"855_CR12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/MCO.0000000000000346","volume":"20","author":"JP Mann","year":"2017","unstructured":"Mann JP, Feldstein AE, Nobili V. Update on lipid species and paediatric nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care. 2017;20(2):110\u20136.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"6","key":"855_CR13","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/hep.21655","volume":"45","author":"K Yamaguchi","year":"2007","unstructured":"Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology. 2007;45(6):1366\u201374.","journal-title":"Hepatology"},{"issue":"2","key":"855_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrendo.2016.169","volume":"13","author":"PJ Meikle","year":"2017","unstructured":"Meikle PJ, Summers SA. Sphingolipids and phospholipids in insulin resistance and related metabolic disorders. Nat Rev Endocrinol. 2017;13(2):79\u201391.","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"855_CR15","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","volume":"26","author":"B Chaurasia","year":"2015","unstructured":"Chaurasia B, Summers SA. Ceramides - Lipotoxic inducers of metabolic disorders. Trends Endocrinol Metab. 2015;26(10):538\u201350.","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"855_CR16","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/liv.12331","volume":"34","author":"K Kurek","year":"2014","unstructured":"Kurek K, Piotrowska DM, Wiesio\u0142ek-Kurek P, \u0141ukaszuk B, Chabowski A, G\u00f3rski J, et al. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease. Liver Int. 2014;34(7):1074\u201383.","journal-title":"Liver Int"},{"issue":"9\u201310","key":"855_CR17","first-page":"995","volume":"26","author":"X Lopez","year":"2013","unstructured":"Lopez X, Goldfine AB, Holland WL, Gordillo R, Scherer PE. Plasma ceramides are elevated in female children and adolescents with type 2 diabetes. J Pediatr Endocrinol Metab. 2013;26(9\u201310):995\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"855_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2337\/db08-1228","volume":"58","author":"JM Haus","year":"2009","unstructured":"Haus JM, Kashyap SR, Kasumov T, Zhang R, Kelly KR, Defronzo RA, et al. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes. 2009;58(2):337\u201343.","journal-title":"Diabetes"},{"issue":"11","key":"855_CR19","doi-asserted-by":"publisher","first-page":"G1102","DOI":"10.1152\/ajpgi.00095.2016","volume":"310","author":"Y Ilan","year":"2016","unstructured":"Ilan Y. Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance. Am J Physiol Gastrointest Liver Physiol. 2016;310(11):G1102\u201317.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"11","key":"855_CR20","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1172\/JCI86013","volume":"126","author":"MC Petersen","year":"2016","unstructured":"Petersen MC, Madiraju AK, Gassaway BM, Marcel M, Nasiri AR, Butrico G, et al. Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance. J Clin Invest. 2016;126(11):4361\u201371.","journal-title":"J Clin Invest"},{"issue":"4","key":"855_CR21","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","volume":"20","author":"SM Turpin","year":"2014","unstructured":"Turpin SM, Nicholls HT, Willmes DM, Mourier A, Brodesser S, Wunderlich CM, et al. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab. 2014;20(4):678\u201386.","journal-title":"Cell Metab"},{"issue":"5","key":"855_CR22","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","volume":"64","author":"PK Luukkonen","year":"2016","unstructured":"Luukkonen PK, Zhou Y, S\u00e4devirta S, Leivonen M, Arola J, Ore\u0161i\u010d M, et al. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. J Hepatol. 2016;64(5):1167\u201375.","journal-title":"J Hepatol"},{"key":"855_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1471-2458-10-109","volume":"10","author":"Z Kulaga","year":"2010","unstructured":"Kulaga Z, Litwin M, Tkaczyk M, R\u00f3zdzy\u0144ska A, Barwicka K, Grajda A, et al. The height-, weight-, and BMI-for-age of polish school-aged children and adolescents relative to international and local growth references. BMC Public Health. 2010;10:109.","journal-title":"BMC Public Health"},{"issue":"7","key":"855_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"issue":"6512","key":"855_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/bmj.292.6512.13","volume":"292","author":"SH Saverymuttu","year":"1986","unstructured":"Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed). 1986;292(6512):13\u20135.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"5","key":"855_CR26","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/MPG.0b013e318252a13f","volume":"54","author":"P Vajro","year":"2012","unstructured":"Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN hepatology committee. J Pediatr Gastroenterol Nutr. 2012;54(5):700\u201313.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"855_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00330-010-1905-5","volume":"21","author":"AE Bohte","year":"2011","unstructured":"Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol. 2011;21(1):87\u201397.","journal-title":"Eur Radiol"},{"issue":"9","key":"855_CR28","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.2337\/db06-0330","volume":"55","author":"F Samad","year":"2006","unstructured":"Samad F, Hester KD, Yang G, Hannun YA, Bielawski J. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes. 2006;55(9):2579\u201387.","journal-title":"Diabetes"},{"issue":"3","key":"855_CR29","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s12020-011-9589-4","volume":"41","author":"I Majumdar","year":"2012","unstructured":"Majumdar I, Mastrandrea LD. Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome. Endocrine. 2012;41(3):442\u20139.","journal-title":"Endocrine"},{"issue":"5","key":"855_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126910","volume":"10","author":"T Kasumov","year":"2015","unstructured":"Kasumov T, Li L, Li M, Gulshan K, Kirwan JP, Liu X, et al. Ceramide as a mediator of non-alcoholic fatty liver disease and associated atherosclerosis. PLoS One. 2015;10(5):e0126910.","journal-title":"PLoS One"},{"issue":"5","key":"855_CR31","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.cmet.2014.10.007","volume":"20","author":"S Raichur","year":"2014","unstructured":"Raichur S, Wang ST, Chan PW, Li Y, Ching J, Chaurasia B, et al. CerS2 Haploinsufficiency inhibits \u03b2-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Cell Metab. 2014;20(5):919.","journal-title":"Cell Metab"},{"issue":"3","key":"855_CR32","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/MPG.0000000000000632","volume":"60","author":"A Dezs\u0151fi","year":"2015","unstructured":"Dezs\u0151fi A, Baumann U, Dhawan A, Durmaz O, Fischler B, Hadzic N, et al. Liver biopsy in children: position paper of the ESPGHAN hepatology committee. J Pediatr Gastroenterol Nutr. 2015;60(3):408\u201320.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"855_CR33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.clinre.2014.02.008","volume":"38","author":"C Della Corte","year":"2014","unstructured":"Della Corte C, Vajro P, Socha P, Nobili V. Pediatric non-alcoholic fatty liver disease: recent advances. Clin Res Hepatol Gastroenterol. 2014;38(4):419\u201322.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"8","key":"855_CR34","first-page":"CR480","volume":"10","author":"M Straczkowski","year":"2004","unstructured":"Straczkowski M, Stepie\u0144 A, Kowalska I, Kinalska I. Comparison of simple indices of insulin sensitivity using the euglycemic hyperinsulinemic clamp technique. Med Sci Monit. 2004;10(8):CR480\u20134.","journal-title":"Med Sci Monit"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0855-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-018-0855-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0855-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T15:38:02Z","timestamp":1569080282000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-018-0855-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,12]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["855"],"URL":"https:\/\/doi.org\/10.1186\/s12944-018-0855-9","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,12]]},"assertion":[{"value":"16 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol was approved by the Bioethics Committee of the Medical University of Bialystok in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"216"}}